Literature DB >> 24240785

Relationship between coronary artery disease and retinopathy in patients with type 2 diabetes mellitus.

Satsuki Kawasaki1, Haruo Misawa, Yasushi Tamura, Yoshinobu Kondo, Shinobu Satoh, Osamu Hasegawa, Satoshi Kato, Yasuo Terauchi.   

Abstract

OBJECTIVE: To examine risk factors for coronary artery disease (CAD) and retinopathy in patients with type 2 diabetes mellitus (DM) and assess the relationship between CAD and retinopathy.
METHODS: A total of 1,003 outpatients with type 2 DM (578 men and 425 women) were classified into two groups according to the presence (based on ischemic findings on a resting electrocardiogram or a history of angina or myocardial infarction) or absence of CAD and four retinopathy stages based on the International Clinical Classification of Diabetic Retinopathy.
RESULTS: Stepwise multiple regression analyses showed that independent risk factors for CAD were age, the triglyceride (TG) level and smoking, while those for retinopathy included age, age of DM diagnosis, the HbA1c level and a female gender. The prevalence of CAD increased in association with the progression of retinopathy (p<0.01).
CONCLUSION: Since it is difficult to distinguish macrovascular and microvascular diseases, diabetic vascular disorders require comprehensive approaches to assessment and treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24240785     DOI: 10.2169/internalmedicine.52.9444

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

Review 1.  Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen.

Authors:  Juan J Chillarón; Juana A Flores-Le Roux; David Benaiges; Juan Pedro-Botet
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

2.  Prospective study on clinical characteristics of Japanese diabetic patients with chronic limb-threatening ischemia presenting Fontaine stage IV.

Authors:  Mitsuyoshi Takahara; Shota Okuno; Izumi Nakamura; Osamu Iida; Takuya Tsujimura; Yosuke Hata; Yukihiro Fujita; Masakazu Haneda
Journal:  Diabetol Int       Date:  2019-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.